HLB Life Science Co., Ltd. (067630.KQ) KOE

3,665.00

-105(-2.79%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap1.13T
Enterprise Value1.2T
P/E Ratio-2.51
PEG Ratio0.02
Price/Sales Ratio5.48
Price/Book Ratio1.61
Enterprise/Revenue7.07
Enterprise/EBITDA-5.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2.19
Operating Margin-0.29

Management Effectiveness

Return On Assets-0.4
Return On Equity-0.54

Income Statement

Revenue102.24B
Revenue/Share668.69
Gross Profit-2.19B
EBITDA26.85B
Net Income6.14B
Diluted EPS54

Balance Sheet

Total Cash24.87B
Total Cash/Share203.99
Total Debt154.4B
Total Debt/Equity0.56
Current Ratio0.93
Book Value Per Share2,274.19

Price History

52-Week Change-61.22
52-Week High11,940
52-Week Low3,105
Moving Average 50 Days4,032.6
Moving Average 200 Days5,082.85

Statistics

Average Volume884,001
Shares Outstanding121.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor525849:500000
Last Split DateDecember 28, 2022